Answers are grounded in this paper and cite their sources.
Review assesses right ventricular function's impact on LVAD performance, suggesting strategies to mitigate dysfunction.
Left ventricular assist devices (LVADs) being increasingly deployed, both as permanent “destination LVADs”, as bridges to cardiac transplantation, for temporary support to support complex percutaneous coronary interventions, for postoperative support of cardiac surgical patients, or for temporary support of acutely decompensated heart failure. These devices are quite effective for the support of the left ventricle but do rely on native right heart function. In this manuscript we review the unique aspects of right ventricular anatomy and physiology, the assessment of right ventricular function, the impact of right ventricular dysfunction on LVAD performance, and strategies to mitigate this impact. We focus on the most common LVADs, the durable and surgically implanted HeartMate III and the temporary, and usually percutaneously placed, Impella.
No takes yet. Share an insight, caveat, or question.
James M. Bailey (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: